ArticleCureus2025
Platypnea-Orthodeoxia Syndrome in Relation to Severe SARS-CoV-2 Infection.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Platypnea-orthodeoxia syndrome (POS) is characterized by dyspnea and oxygen desaturation in the upright position, caused by arteriovenous shunts (intracardiac, intrapulmonary, or physiological). In recent years, POS has been described in patients with SARS-CoV-2 infection, in both acute and rehabilitation phases. This case describes a 90-year-old man who presented to the emergency department with a dry cough and dyspnea and was diagnosed with severe SARS-CoV-2 infection. He underwent non-invasive ventilation for refractory hypoxemia. During convalescence, CT scans revealed fibrotic changes predominantly in the lung bases. He experienced persistent dyspnea and oxygen desaturation upon standing. Blood gas analysis confirmed orthodeoxia. After ruling out intracardiac and intrapulmonary shunts, secondary POS due to SARS-CoV-2 infection was presumed. He continued rehabilitation with progressive improvement, resolving the condition a month after discharge. This phenomenon, likely induced by fibrotic sequelae of SARS-CoV-2 in the lung bases causing a physiological shunt, highlights a potentially underdiagnosed complication of interstitial lung diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.